Unresolved intramuscular inflammation, not diminished skeletal muscle regenerative capacity, is at the root of rheumatoid cachexia: insights from a rat CIA model

Rheumatoid arthritis targets numerous organs in patients, including the skeletal muscle, resulting in rheumatoid cachexia. In the muscle niche, satellite cells, macrophages, and myofibroblasts may be affected and the factors they release altered. This study aimed to assess these cell types, cytokines, and growth factors and their relationships to muscle fiber size and number in a rodent collagen‐induced arthritis (CIA) model, in order to identify new therapeutic targets. Fiber cross‐sectional area (CSA) was 57% lower in CIA than controls (p < 0.0001), thus smaller but more fibers visible per field of view. Immunostaining indicated the increased presence of satellite cells, macrophages, myofibroblasts, and myonuclei per field of view in CIA (p < 0.01), but this finding was not maintained when taking fiber number into consideration. Western blots of gastrocnemius samples indicated that tumor necrosis factor‐α was significantly elevated (p < 0.01) while interleukin‐10 (IL‐10) was decreased (p < 0.05) in CIA. This effect was maintained (and heightened for IL‐10) when expressed per fiber number. Myogenic regulatory factors (MyoD and myogenin), transforming growth factor‐β and inhibitor of differentiation were significantly elevated in CIA muscle and levels correlated significantly with CSA. Several of these factors remained elevated, but bone morphogenetic protein‐7 decreased when considering fiber number per area. In conclusion, CIA‐muscle demonstrated a good regenerative response. Myoblast numbers per fiber were not elevated, suggesting their activity results from the persistent inflammatory signaling which also significantly hampered maintenance of muscle fiber size. A clearer picture of signaling events at cellular level in arthritis muscle may be derived from expressing data per fiber.

[1]  K. Myburgh,et al.  Rheumatoid cachexia: the underappreciated role of myoblast, macrophage and fibroblast interplay in the skeletal muscle niche , 2021, Journal of Biomedical Science.

[2]  Wei-Hsin Sun,et al.  Temporal expression patterns of distinct cytokines and M1/M2 macrophage polarization regulate rheumatoid arthritis progression , 2020, Molecular Biology Reports.

[3]  Congxin Huang,et al.  Over-Expression of Inhibitor of Differentiation 2 Attenuates Post-Infarct Cardiac Fibrosis Through Inhibition of TGF-β1/Smad3/HIF-1α/IL-11 Signaling Pathway , 2019, Front. Pharmacol..

[4]  R. Lucchetti,et al.  Porphyromonas gingivalis and rheumatoid arthritis. , 2019, Current opinion in rheumatology.

[5]  T. Wynn Two types of fibroblast drive arthritis , 2019, Nature.

[6]  C. Svensson,et al.  Oxidative hotspots on actin promote skeletal muscle weakness in rheumatoid arthritis. , 2019, JCI insight.

[7]  A. Oyenihi,et al.  Redox Status and Muscle Pathology in Rheumatoid Arthritis: Insights from Various Rat Hindlimb Muscles , 2019, Oxidative medicine and cellular longevity.

[8]  A. Hatzopoulos,et al.  Bone morphogenetic protein signaling in inflammation , 2019, Experimental biology and medicine.

[9]  R. Xavier,et al.  Prevalence of rheumatoid cachexia in rheumatoid arthritis: a systematic review and meta‐analysis , 2018, Journal of cachexia, sarcopenia and muscle.

[10]  M. Kjaer,et al.  Skeletal muscle stem cell characteristics and myonuclei content in patients with rheumatoid arthritis: a cross-sectional study , 2018, Rheumatology International.

[11]  M. Ciemerych,et al.  The role of TGF‐β1 during skeletal muscle regeneration , 2017, Cell biology international.

[12]  W. Kraus,et al.  Molecular alterations in skeletal muscle in rheumatoid arthritis are related to disease activity, physical inactivity, and disability , 2017, Arthritis Research & Therapy.

[13]  T. Mimura,et al.  The Mechanisms Underlying Chronic Inflammation in Rheumatoid Arthritis from the Perspective of the Epigenetic Landscape , 2016, Journal of immunology research.

[14]  C. Gómez-Moreira,et al.  Formoterol decreases muscle wasting as well as inflammation in the rat model of rheumatoid arthritis. , 2016, American journal of physiology. Endocrinology and metabolism.

[15]  Jing Wang,et al.  BMP-7 Treatment Increases M2 Macrophage Differentiation and Reduces Inflammation and Plaque Formation in Apo E-/- Mice , 2016, PloS one.

[16]  Xiong Cai,et al.  Phenotypic characterization of type II collagen-induced arthritis in Wistar rats. , 2015, Experimental and therapeutic medicine.

[17]  K. Masuko Rheumatoid Cachexia Revisited: A Metabolic Co-Morbidity in Rheumatoid Arthritis , 2014, Front. Nutr..

[18]  S. Bodine,et al.  Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1. , 2014, American journal of physiology. Endocrinology and metabolism.

[19]  L. Larsson,et al.  The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass , 2013, The Journal of cell biology.

[20]  K. Fukuzaki,et al.  Muscle wasting associated with pathologic change is a risk factor for the exacerbation of joint swelling in collagen-induced arthritis in cynomolgus monkeys , 2013, BMC Musculoskeletal Disorders.

[21]  B. Pedersen,et al.  Interleukin‐6 myokine signaling in skeletal muscle: a double‐edged sword? , 2013, The FEBS journal.

[22]  R. Xavier,et al.  Temporal development of muscle atrophy in murine model of arthritis is related to disease severity , 2013, Journal of cachexia, sarcopenia and muscle.

[23]  G. Butler-Browne,et al.  Proinflammatory macrophages enhance the regenerative capacity of human myoblasts by modifying their kinetics of proliferation and differentiation. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[24]  H. L. Wright,et al.  Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy. , 2012, Rheumatology.

[25]  R. Xavier,et al.  Mechanisms of muscle wasting in sarcopenia. , 2012, Revista Brasileira de Reumatologia.

[26]  J. Thom,et al.  Skeletal muscle properties in rheumatoid arthritis patients. , 2010, Medicine and science in sports and exercise.

[27]  E. Castillero,et al.  Systemic IGF-I administration attenuates the inhibitory effect of chronic arthritis on gastrocnemius mass and decreases atrogin-1 and IGFBP-3. , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.

[28]  E. Castillero,et al.  IGF-I system, atrogenes and myogenic regulatory factors in arthritis induced muscle wasting , 2009, Molecular and Cellular Endocrinology.

[29]  I. McInnes,et al.  Animal models of rheumatoid arthritis , 2009, European journal of immunology.

[30]  K. Moudgil,et al.  CHAPTER 8N – Animal Models , 2009 .

[31]  Iain B McInnes,et al.  Evidence that cytokines play a role in rheumatoid arthritis. , 2008, The Journal of clinical investigation.

[32]  P. Muñoz-Cánoves,et al.  Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. , 2008, Cell metabolism.

[33]  A. Koch The pathogenesis of rheumatoid arthritis. , 2007, American journal of orthopedics.

[34]  Frank A Witzmann,et al.  Tumor Necrosis Factor-α -and Interleukin-1-Induced Cellular Responses: Coupling Proteomic and Genomic Information , 2007 .

[35]  N. Van Rooijen,et al.  Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis , 2007, The Journal of experimental medicine.

[36]  K. Saag,et al.  Treatment of rheumatoid arthritis. , 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[37]  S. Friedman,et al.  BMP-7 opposes TGF-beta1-mediated collagen induction in mouse pulmonary myofibroblasts through Id2. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[38]  D. Kimpel,et al.  Animal models of rheumatoid arthritis and their relevance to human disease. , 2005, Pathophysiology : the official journal of the International Society for Pathophysiology.

[39]  D. Cooper,et al.  IL-6-induced skeletal muscle atrophy. , 2005, Journal of applied physiology.

[40]  D. Mann,et al.  TNF-acts via p 38 MAPK to stimulate expression of the ubiquitin ligase atrogin 1 / MAFbx in skeletal muscle , 2005 .

[41]  J. Dayer The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis. , 2003, Rheumatology.

[42]  S. Alway,et al.  Id2 expression during apoptosis and satellite cell activation in unloaded and loaded quail skeletal muscles. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[43]  R. Roubenoff,et al.  Cachexia in rheumatoid arthritis. , 2002, International journal of cardiology.

[44]  J. Dayer Interleukin 1 or tumor necrosis factor-alpha: which is the real target in rheumatoid arthritis? , 2002, The Journal of rheumatology. Supplement.

[45]  P. Lengyel,et al.  The MyoD-Inducible p204 Protein Overcomes the Inhibition of Myoblast Differentiation by Id Proteins , 2002, Molecular and Cellular Biology.

[46]  J. Kehayias,et al.  Adjuvant arthritis as a model of inflammatory cachexia. , 1997, Arthritis and rheumatism.

[47]  P. Helliwell,et al.  Relationship between weakness and muscle wasting in rheumatoid arthritis. , 1994, Annals of the rheumatic diseases.

[48]  J. Kehayias,et al.  Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. , 1994, The Journal of clinical investigation.

[49]  H. Weintraub,et al.  Overexpression of Id protein inhibits the muscle differentiation program: in vivo association of Id with E2A proteins. , 1992, Genes & development.

[50]  M. Feldmann,et al.  Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. , 1991, Arthritis and rheumatism.

[51]  H. Finol,et al.  Ultrastructure of skeletal muscle in rheumatoid myositis. , 1988, The Journal of rheumatology.

[52]  B. Beutler,et al.  Brief Definitive Report Cachectin/tumor Necrosis Factor Stimulates Collagenase and Prostaglandin E2 Production by Human Synovial Cells and Dermal , 2022 .

[53]  L. Sokoloff,et al.  Animal models of rheumatoid arthritis. , 1984, International review of experimental pathology.